Novavax Inc (NVAX)
8.47
+0.43
(+5.35%)
USD |
NASDAQ |
Nov 22, 16:00
8.44
-0.03
(-0.35%)
After-Hours: 20:00
Novavax Cash from Investing (Quarterly): 31.91M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 31.91M |
| June 30, 2024 | -372.71M |
| March 31, 2024 | -7.25M |
| December 31, 2023 | -9.078M |
| September 30, 2023 | -18.39M |
| June 30, 2023 | -7.779M |
| March 31, 2023 | -23.56M |
| December 31, 2022 | -22.06M |
| September 30, 2022 | -29.52M |
| June 30, 2022 | -24.58M |
| March 31, 2022 | -16.83M |
| December 31, 2021 | -16.36M |
| September 30, 2021 | -12.19M |
| June 30, 2021 | -12.90M |
| March 31, 2021 | 141.61M |
| December 31, 2020 | -31.12M |
| September 30, 2020 | -100.71M |
| June 30, 2020 | -188.22M |
| March 31, 2020 | -57.73M |
| December 31, 2019 | -0.216M |
| September 30, 2019 | 17.97M |
| June 30, 2019 | 2.024M |
| March 31, 2019 | 18.71M |
| December 31, 2018 | 48.32M |
| September 30, 2018 | 7.996M |
| Date | Value |
|---|---|
| June 30, 2018 | -48.30M |
| March 31, 2018 | 20.59M |
| December 31, 2017 | 16.76M |
| September 30, 2017 | 41.96M |
| June 30, 2017 | 2.531M |
| March 31, 2017 | -25.28M |
| December 31, 2016 | 85.90M |
| September 30, 2016 | 92.57M |
| June 30, 2016 | 18.98M |
| March 31, 2016 | -169.44M |
| December 31, 2015 | 9.559M |
| September 30, 2015 | -9.21M |
| June 30, 2015 | -39.41M |
| March 31, 2015 | 17.79M |
| December 31, 2014 | 17.35M |
| September 30, 2014 | -54.10M |
| June 30, 2014 | -102.78M |
| March 31, 2014 | 9.701M |
| December 31, 2013 | 9.161M |
| September 30, 2013 | 15.41M |
| June 30, 2013 | -3.207M |
| March 31, 2013 | -4.974M |
| December 31, 2012 | -17.12M |
| September 30, 2012 | -7.349M |
| June 30, 2012 | -4.528M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-372.71M
Minimum
Jun 2024
141.61M
Maximum
Mar 2021
-38.88M
Average
-17.61M
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | -2.057B |
| Moderna Inc | 721.00M |
| Inovio Pharmaceuticals Inc | 14.08M |
| Baxter International Inc | -164.00M |
| Halozyme Therapeutics Inc | -167.48M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -144.81M |
| Cash from Financing (Quarterly) | -0.097M |
| Free Cash Flow | -112.35M |
| Free Cash Flow Per Share (Quarterly) | -0.9174 |
| Free Cash Flow to Equity (Quarterly) | -147.24M |
| Free Cash Flow to Firm (Quarterly) | -142.63M |
| Free Cash Flow Yield | -9.00% |